RxDoctor Payments Data

Alexander Green, MD

Clinical Cardiac Electrophysiology · Maywood, ILNPI 1093896284

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $47,291 of the $73,723 with a category attached, or 64.1%. Abbott accounts for 69.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $41,297 and has fallen 96.2% since, to $1,571 in 2025.

$73,723in general payments, 2019–2025

Across 303 payments — averaging $243.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$51K
  • Pfizer$8K
  • E.r. Squibb & Sons, L.L.C.$5K
  • Philips North America LLC$3K
  • Cook Incorporated$2K
  • Biosense Webster, Inc.$2K
  • plus $3K from 13 others

What the payments were for

  • Consulting fees$47,29164%
  • Speaking & faculty fees$13,89019%
  • Travel & lodging$4,4506%
  • Food & beverage$8,09211%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$73,723 in reported general payments places this provider in the 80th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$290,136
Medicare patients
2,555
Services billed
5,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban242$266,579
MultaqDronedarone Hcl62$94,919
XareltoRivaroxaban70$88,240
CorlanorIvabradine Hcl14$8,216
Amiodarone Hcl104$3,241
Metoprolol Succinate170$2,431
SotalolSotalol Hcl90$1,840
Flecainide Acetate62$1,778
Metoprolol Tartrate28$371
Hydrochlorothiazide12$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$8,028$266,579242 claims
Johnson & JohnsonXarelto$19$88,24070 claims
AmgenCorlanor$24$8,21614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

Other clinical cardiac electrophysiology in Maywood

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →